Self Glucose Monitoring Market

Self-Monitoring of Blood Glucose (SMBG) is an approach whereby people with diabetes measure their blood sugar (glycemia) themselves using a glycemic reader (glucose meter). Based on the reading, they can adjust or check the effect of their treatment (diet, exercise, insulin, antidiabetics, stress management).

Self Glucose Monitoring Market contains market size and forecasts of Self Glucose Monitoring in global, including the following market information:

Global Self Glucose Monitoring Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Self Glucose Monitoring Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Self Glucose Monitoring companies in 2021 (%)

The global Self Glucose Monitoring market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Blood Glucose Meter Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Self Glucose Monitoring include Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices and Nova Biomedical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Self Glucose Monitoring manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Self Glucose Monitoring Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Self Glucose Monitoring Market Segment Percentages, by Type, 2021 (%)

• Blood Glucose Meter
• Blood Glucose Testing Strips

Global Self Glucose Monitoring Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Self Glucose Monitoring Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Self Glucose Monitoring Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Self Glucose Monitoring Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Self Glucose Monitoring revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Self Glucose Monitoring revenues share in global market, 2021 (%)
• Key companies Self Glucose Monitoring sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Self Glucose Monitoring sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Medtronic
• Roche
• Bayer AG
• B. Braun
• Nipro Diagnostics
• Life Scan Inc.(J&J)
• Arkray Devices
• Nova Biomedical
• Bionime Corporation